カテゴリー： 世界, 医療/バイオ, LP Information

世界の組換えヒト血清アルブミン市場予測 2023年-2029年

【英語タイトル】Global Recombinant Human Serum Albumin Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC11411）・商品コード：LP23DC11411
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：90
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の組換えヒト血清アルブミン市場」は、過去の販売実績から2022年の世界の組換えヒト血清アルブミンの総販売量を検討し、2023年から2029年の予測される組換えヒト血清アルブミンの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の組換えヒト血清アルブミンの市場規模を掲載し、XXX百万米ドル規模の世界の組換えヒト血清アルブミン市場の詳細な分析を提供します。本インサイトレポートは、世界の組換えヒト血清アルブミン業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の組換えヒト血清アルブミン市場における各社の独自のポジションをより深く理解するために、組換えヒト血清アルブミン製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の組換えヒト血清アルブミン市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。組換えヒト血清アルブミンの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。組換えヒト血清アルブミンの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。組換えヒト血清アルブミンのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

組換えヒト血清アルブミンの世界主要メーカーとしては、Albumedix、 Merck、 Ventria (InVitria)、 NCPC、 Oryzogen、 HiMediaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の組換えヒト血清アルブミン市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では組換えヒト血清アルブミン市場をセグメンテーションし、種類別 (OsrHSA、ScrHSA)、用途別 (細胞培養培地、医療サプリメント、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：OsrHSA、ScrHSA

・用途別区分：細胞培養培地、医療サプリメント、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の組換えヒト血清アルブミン市場の10年間の市場状況・展望は？
・世界および地域別に見た組換えヒト血清アルブミン市場成長の要因は何か？
・組換えヒト血清アルブミンの市場機会はエンドマーケットの規模によってどのように変化するのか？
・組換えヒト血清アルブミンのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：組換えヒト血清アルブミンの年間販売量2018-2029、地域別現状・将来分析
・組換えヒト血清アルブミンの種類別セグメント：OsrHSA、ScrHSA
・組換えヒト血清アルブミンの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・組換えヒト血清アルブミンの用途別セグメント：細胞培養培地、医療サプリメント、その他
・組換えヒト血清アルブミンの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の組換えヒト血清アルブミン市場
・企業別のグローバル組換えヒト血清アルブミン市場データ：2018-2023年の年間販売量、市場シェア
・企業別の組換えヒト血清アルブミンの年間売上：2018-2023年の売上、市場シェア
・企業別の組換えヒト血清アルブミン販売価格
・主要企業の組換えヒト血清アルブミン生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

組換えヒト血清アルブミンの地域別レビュー
・地域別の組換えヒト血清アルブミン市場規模2018-2023：年間販売量、売上
・主要国別の組換えヒト血清アルブミン市場規模2018-2023：年間販売量、売上
・南北アメリカの組換えヒト血清アルブミン販売の成長
・アジア太平洋の組換えヒト血清アルブミン販売の成長
・ヨーロッパの組換えヒト血清アルブミン販売の成長
・中東・アフリカの組換えヒト血清アルブミン販売の成長

南北アメリカ市場
・南北アメリカの国別の組換えヒト血清アルブミン販売量、売上（2018-2023）
・南北アメリカの組換えヒト血清アルブミンの種類別販売量
・南北アメリカの組換えヒト血清アルブミンの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の組換えヒト血清アルブミン販売量、売上（2018-2023）
・アジア太平洋の組換えヒト血清アルブミンの種類別販売量
・アジア太平洋の組換えヒト血清アルブミンの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の組換えヒト血清アルブミン販売量、売上（2018-2023）
・ヨーロッパの組換えヒト血清アルブミンの種類別販売量
・ヨーロッパの組換えヒト血清アルブミンの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の組換えヒト血清アルブミン販売量、売上（2018-2023）
・中東・アフリカの組換えヒト血清アルブミンの種類別販売量
・中東・アフリカの組換えヒト血清アルブミンの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・組換えヒト血清アルブミンの製造コスト構造分析
・組換えヒト血清アルブミンの製造プロセス分析
・組換えヒト血清アルブミンの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・組換えヒト血清アルブミンの主要なグローバル販売業者
・組換えヒト血清アルブミンの主要なグローバル顧客

地域別の組換えヒト血清アルブミン市場予測レビュー
・地域別の組換えヒト血清アルブミン市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・組換えヒト血清アルブミンの種類別市場規模予測
・組換えヒト血清アルブミンの用途別市場規模予測

主要企業分析
Albumedix、 Merck、 Ventria (InVitria)、 NCPC、 Oryzogen、 HiMedia
・企業情報
・組換えヒト血清アルブミン製品
・組換えヒト血清アルブミン販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Recombinant Human Serum Albumin market size is projected to grow from US$ 73 million in 2022 to US$ 121.9 million in 2029; it is expected to grow at a CAGR of 7.6% from 2023 to 2029.
Global key players of recombinant human serum albumin (Recombinant Human Serum Albumin) include Albumedix, Merck and Ventria (InVitria). The top three manufacturers account for about 88% of the global share. North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively. North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively. In terms of product type, ScrHSA is the largest segment, holding about 91% share. In terms of application, cell culture media is the largest downstream segment with about 73% share; followed by medical supplements.
Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
LPI (LP Information)’ newest research report, the “Recombinant Human Serum Albumin Industry Forecast” looks at past sales and reviews total world Recombinant Human Serum Albumin sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Human Serum Albumin sales for 2023 through 2029. With Recombinant Human Serum Albumin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Serum Albumin industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Human Serum Albumin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Serum Albumin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Serum Albumin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Serum Albumin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Serum Albumin.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Serum Albumin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
OsrHSA
ScrHSA
Segmentation by application
Cell Culture Media
Medical Supplements
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Key Questions Addressed in this Report
What is the 10-year outlook for the global Recombinant Human Serum Albumin market?
What factors are driving Recombinant Human Serum Albumin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Human Serum Albumin market opportunities vary by end market size?
How does Recombinant Human Serum Albumin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Recombinant Human Serum Albumin Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Human Serum Albumin by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Human Serum Albumin by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Human Serum Albumin Segment by Type
2.2.1 OsrHSA
2.2.2 ScrHSA
2.3 Recombinant Human Serum Albumin Sales by Type
2.3.1 Global Recombinant Human Serum Albumin Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Human Serum Albumin Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Human Serum Albumin Sale Price by Type (2018-2023)
2.4 Recombinant Human Serum Albumin Segment by Application
2.4.1 Cell Culture Media
2.4.2 Medical Supplements
2.4.3 Other
2.5 Recombinant Human Serum Albumin Sales by Application
2.5.1 Global Recombinant Human Serum Albumin Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Human Serum Albumin Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Human Serum Albumin Sale Price by Application (2018-2023)
3 Global Recombinant Human Serum Albumin by Company
3.1 Global Recombinant Human Serum Albumin Breakdown Data by Company
3.1.1 Global Recombinant Human Serum Albumin Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Human Serum Albumin Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Human Serum Albumin Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Human Serum Albumin Revenue by Company (2018-2023)
3.2.2 Global Recombinant Human Serum Albumin Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Human Serum Albumin Sale Price by Company
3.4 Key Manufacturers Recombinant Human Serum Albumin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Human Serum Albumin Product Location Distribution
3.4.2 Players Recombinant Human Serum Albumin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Recombinant Human Serum Albumin by Geographic Region
4.1 World Historic Recombinant Human Serum Albumin Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Human Serum Albumin Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Human Serum Albumin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Human Serum Albumin Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Human Serum Albumin Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Human Serum Albumin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Human Serum Albumin Sales Growth
4.4 APAC Recombinant Human Serum Albumin Sales Growth
4.5 Europe Recombinant Human Serum Albumin Sales Growth
4.6 Middle East & Africa Recombinant Human Serum Albumin Sales Growth
5 Americas
5.1 Americas Recombinant Human Serum Albumin Sales by Country
5.1.1 Americas Recombinant Human Serum Albumin Sales by Country (2018-2023)
5.1.2 Americas Recombinant Human Serum Albumin Revenue by Country (2018-2023)
5.2 Americas Recombinant Human Serum Albumin Sales by Type
5.3 Americas Recombinant Human Serum Albumin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Human Serum Albumin Sales by Region
6.1.1 APAC Recombinant Human Serum Albumin Sales by Region (2018-2023)
6.1.2 APAC Recombinant Human Serum Albumin Revenue by Region (2018-2023)
6.2 APAC Recombinant Human Serum Albumin Sales by Type
6.3 APAC Recombinant Human Serum Albumin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Recombinant Human Serum Albumin by Country
7.1.1 Europe Recombinant Human Serum Albumin Sales by Country (2018-2023)
7.1.2 Europe Recombinant Human Serum Albumin Revenue by Country (2018-2023)
7.2 Europe Recombinant Human Serum Albumin Sales by Type
7.3 Europe Recombinant Human Serum Albumin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Recombinant Human Serum Albumin by Country
8.1.1 Middle East & Africa Recombinant Human Serum Albumin Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Human Serum Albumin Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Human Serum Albumin Sales by Type
8.3 Middle East & Africa Recombinant Human Serum Albumin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Human Serum Albumin
10.3 Manufacturing Process Analysis of Recombinant Human Serum Albumin
10.4 Industry Chain Structure of Recombinant Human Serum Albumin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Human Serum Albumin Distributors
11.3 Recombinant Human Serum Albumin Customer
12 World Forecast Review for Recombinant Human Serum Albumin by Geographic Region
12.1 Global Recombinant Human Serum Albumin Market Size Forecast by Region
12.1.1 Global Recombinant Human Serum Albumin Forecast by Region (2024-2029)
12.1.2 Global Recombinant Human Serum Albumin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Human Serum Albumin Forecast by Type
12.7 Global Recombinant Human Serum Albumin Forecast by Application
13 Key Players Analysis
13.1 Albumedix
13.1.1 Albumedix Company Information
13.1.2 Albumedix Recombinant Human Serum Albumin Product Portfolios and Specifications
13.1.3 Albumedix Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Albumedix Main Business Overview
13.1.5 Albumedix Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Recombinant Human Serum Albumin Product Portfolios and Specifications
13.2.3 Merck Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Ventria (InVitria)
13.3.1 Ventria (InVitria) Company Information
13.3.2 Ventria (InVitria) Recombinant Human Serum Albumin Product Portfolios and Specifications
13.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ventria (InVitria) Main Business Overview
13.3.5 Ventria (InVitria) Latest Developments
13.4 NCPC
13.4.1 NCPC Company Information
13.4.2 NCPC Recombinant Human Serum Albumin Product Portfolios and Specifications
13.4.3 NCPC Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 NCPC Main Business Overview
13.4.5 NCPC Latest Developments
13.5 Oryzogen
13.5.1 Oryzogen Company Information
13.5.2 Oryzogen Recombinant Human Serum Albumin Product Portfolios and Specifications
13.5.3 Oryzogen Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Oryzogen Main Business Overview
13.5.5 Oryzogen Latest Developments
13.6 HiMedia
13.6.1 HiMedia Company Information
13.6.2 HiMedia Recombinant Human Serum Albumin Product Portfolios and Specifications
13.6.3 HiMedia Recombinant Human Serum Albumin Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 HiMedia Main Business Overview
13.6.5 HiMedia Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Recombinant Human Serum Albumin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Human Serum Albumin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of OsrHSA
Table 4. Major Players of ScrHSA
Table 5. Global Recombinant Human Serum Albumin Sales by Type (2018-2023) & (Kg)
Table 6. Global Recombinant Human Serum Albumin Sales Market Share by Type (2018-2023)
Table 7. Global Recombinant Human Serum Albumin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Recombinant Human Serum Albumin Revenue Market Share by Type (2018-2023)
Table 9. Global Recombinant Human Serum Albumin Sale Price by Type (2018-2023) & (US$/g)
Table 10. Global Recombinant Human Serum Albumin Sales by Application (2018-2023) & (Kg)
Table 11. Global Recombinant Human Serum Albumin Sales Market Share by Application (2018-2023)
Table 12. Global Recombinant Human Serum Albumin Revenue by Application (2018-2023)
Table 13. Global Recombinant Human Serum Albumin Revenue Market Share by Application (2018-2023)
Table 14. Global Recombinant Human Serum Albumin Sale Price by Application (2018-2023) & (US$/g)
Table 15. Global Recombinant Human Serum Albumin Sales by Company (2018-2023) & (Kg)
Table 16. Global Recombinant Human Serum Albumin Sales Market Share by Company (2018-2023)
Table 17. Global Recombinant Human Serum Albumin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Recombinant Human Serum Albumin Revenue Market Share by Company (2018-2023)
Table 19. Global Recombinant Human Serum Albumin Sale Price by Company (2018-2023) & (US$/g)
Table 20. Key Manufacturers Recombinant Human Serum Albumin Producing Area Distribution and Sales Area
Table 21. Players Recombinant Human Serum Albumin Products Offered
Table 22. Recombinant Human Serum Albumin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant Human Serum Albumin Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Recombinant Human Serum Albumin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Recombinant Human Serum Albumin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Recombinant Human Serum Albumin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Recombinant Human Serum Albumin Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Recombinant Human Serum Albumin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Recombinant Human Serum Albumin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Recombinant Human Serum Albumin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Recombinant Human Serum Albumin Sales by Country (2018-2023) & (Kg)
Table 34. Americas Recombinant Human Serum Albumin Sales Market Share by Country (2018-2023)
Table 35. Americas Recombinant Human Serum Albumin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Recombinant Human Serum Albumin Revenue Market Share by Country (2018-2023)
Table 37. Americas Recombinant Human Serum Albumin Sales by Type (2018-2023) & (Kg)
Table 38. Americas Recombinant Human Serum Albumin Sales by Application (2018-2023) & (Kg)
Table 39. APAC Recombinant Human Serum Albumin Sales by Region (2018-2023) & (Kg)
Table 40. APAC Recombinant Human Serum Albumin Sales Market Share by Region (2018-2023)
Table 41. APAC Recombinant Human Serum Albumin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Recombinant Human Serum Albumin Revenue Market Share by Region (2018-2023)
Table 43. APAC Recombinant Human Serum Albumin Sales by Type (2018-2023) & (Kg)
Table 44. APAC Recombinant Human Serum Albumin Sales by Application (2018-2023) & (Kg)
Table 45. Europe Recombinant Human Serum Albumin Sales by Country (2018-2023) & (Kg)
Table 46. Europe Recombinant Human Serum Albumin Sales Market Share by Country (2018-2023)
Table 47. Europe Recombinant Human Serum Albumin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Recombinant Human Serum Albumin Revenue Market Share by Country (2018-2023)
Table 49. Europe Recombinant Human Serum Albumin Sales by Type (2018-2023) & (Kg)
Table 50. Europe Recombinant Human Serum Albumin Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Recombinant Human Serum Albumin Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Recombinant Human Serum Albumin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Recombinant Human Serum Albumin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Recombinant Human Serum Albumin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Recombinant Human Serum Albumin Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Recombinant Human Serum Albumin Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Recombinant Human Serum Albumin
Table 58. Key Market Challenges & Risks of Recombinant Human Serum Albumin
Table 59. Key Industry Trends of Recombinant Human Serum Albumin
Table 60. Recombinant Human Serum Albumin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Recombinant Human Serum Albumin Distributors List
Table 63. Recombinant Human Serum Albumin Customer List
Table 64. Global Recombinant Human Serum Albumin Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Recombinant Human Serum Albumin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Recombinant Human Serum Albumin Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Recombinant Human Serum Albumin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Recombinant Human Serum Albumin Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Recombinant Human Serum Albumin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Recombinant Human Serum Albumin Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Recombinant Human Serum Albumin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Recombinant Human Serum Albumin Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Recombinant Human Serum Albumin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Recombinant Human Serum Albumin Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Recombinant Human Serum Albumin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Recombinant Human Serum Albumin Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Recombinant Human Serum Albumin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Albumedix Basic Information, Recombinant Human Serum Albumin Manufacturing Base, Sales Area and Its Competitors
Table 79. Albumedix Recombinant Human Serum Albumin Product Portfolios and Specifications
Table 80. Albumedix Recombinant Human Serum Albumin Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 81. Albumedix Main Business
Table 82. Albumedix Latest Developments
Table 83. Merck Basic Information, Recombinant Human Serum Albumin Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Recombinant Human Serum Albumin Product Portfolios and Specifications
Table 85. Merck Recombinant Human Serum Albumin Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Ventria (InVitria) Basic Information, Recombinant Human Serum Albumin Manufacturing Base, Sales Area and Its Competitors
Table 89. Ventria (InVitria) Recombinant Human Serum Albumin Product Portfolios and Specifications
Table 90. Ventria (InVitria) Recombinant Human Serum Albumin Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 91. Ventria (InVitria) Main Business
Table 92. Ventria (InVitria) Latest Developments
Table 93. NCPC Basic Information, Recombinant Human Serum Albumin Manufacturing Base, Sales Area and Its Competitors
Table 94. NCPC Recombinant Human Serum Albumin Product Portfolios and Specifications
Table 95. NCPC Recombinant Human Serum Albumin Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 96. NCPC Main Business
Table 97. NCPC Latest Developments
Table 98. Oryzogen Basic Information, Recombinant Human Serum Albumin Manufacturing Base, Sales Area and Its Competitors
Table 99. Oryzogen Recombinant Human Serum Albumin Product Portfolios and Specifications
Table 100. Oryzogen Recombinant Human Serum Albumin Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 101. Oryzogen Main Business
Table 102. Oryzogen Latest Developments
Table 103. HiMedia Basic Information, Recombinant Human Serum Albumin Manufacturing Base, Sales Area and Its Competitors
Table 104. HiMedia Recombinant Human Serum Albumin Product Portfolios and Specifications
Table 105. HiMedia Recombinant Human Serum Albumin Sales (Kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2018-2023)
Table 106. HiMedia Main Business
Table 107. HiMedia Latest Developments
List of Figures
Figure 1. Picture of Recombinant Human Serum Albumin
Figure 2. Recombinant Human Serum Albumin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Human Serum Albumin Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Recombinant Human Serum Albumin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Human Serum Albumin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of OsrHSA
Figure 10. Product Picture of ScrHSA
Figure 11. Global Recombinant Human Serum Albumin Sales Market Share by Type in 2022
Figure 12. Global Recombinant Human Serum Albumin Revenue Market Share by Type (2018-2023)
Figure 13. Recombinant Human Serum Albumin Consumed in Cell Culture Media
Figure 14. Global Recombinant Human Serum Albumin Market: Cell Culture Media (2018-2023) & (Kg)
Figure 15. Recombinant Human Serum Albumin Consumed in Medical Supplements
Figure 16. Global Recombinant Human Serum Albumin Market: Medical Supplements (2018-2023) & (Kg)
Figure 17. Recombinant Human Serum Albumin Consumed in Other
Figure 18. Global Recombinant Human Serum Albumin Market: Other (2018-2023) & (Kg)
Figure 19. Global Recombinant Human Serum Albumin Sales Market Share by Application (2022)
Figure 20. Global Recombinant Human Serum Albumin Revenue Market Share by Application in 2022
Figure 21. Recombinant Human Serum Albumin Sales Market by Company in 2022 (Kg)
Figure 22. Global Recombinant Human Serum Albumin Sales Market Share by Company in 2022
Figure 23. Recombinant Human Serum Albumin Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Recombinant Human Serum Albumin Revenue Market Share by Company in 2022
Figure 25. Global Recombinant Human Serum Albumin Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Recombinant Human Serum Albumin Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Recombinant Human Serum Albumin Sales 2018-2023 (Kg)
Figure 28. Americas Recombinant Human Serum Albumin Revenue 2018-2023 ($ Millions)
Figure 29. APAC Recombinant Human Serum Albumin Sales 2018-2023 (Kg)
Figure 30. APAC Recombinant Human Serum Albumin Revenue 2018-2023 ($ Millions)
Figure 31. Europe Recombinant Human Serum Albumin Sales 2018-2023 (Kg)
Figure 32. Europe Recombinant Human Serum Albumin Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Recombinant Human Serum Albumin Sales 2018-2023 (Kg)
Figure 34. Middle East & Africa Recombinant Human Serum Albumin Revenue 2018-2023 ($ Millions)
Figure 35. Americas Recombinant Human Serum Albumin Sales Market Share by Country in 2022
Figure 36. Americas Recombinant Human Serum Albumin Revenue Market Share by Country in 2022
Figure 37. Americas Recombinant Human Serum Albumin Sales Market Share by Type (2018-2023)
Figure 38. Americas Recombinant Human Serum Albumin Sales Market Share by Application (2018-2023)
Figure 39. United States Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Recombinant Human Serum Albumin Sales Market Share by Region in 2022
Figure 44. APAC Recombinant Human Serum Albumin Revenue Market Share by Regions in 2022
Figure 45. APAC Recombinant Human Serum Albumin Sales Market Share by Type (2018-2023)
Figure 46. APAC Recombinant Human Serum Albumin Sales Market Share by Application (2018-2023)
Figure 47. China Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Recombinant Human Serum Albumin Sales Market Share by Country in 2022
Figure 55. Europe Recombinant Human Serum Albumin Revenue Market Share by Country in 2022
Figure 56. Europe Recombinant Human Serum Albumin Sales Market Share by Type (2018-2023)
Figure 57. Europe Recombinant Human Serum Albumin Sales Market Share by Application (2018-2023)
Figure 58. Germany Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Recombinant Human Serum Albumin Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Human Serum Albumin Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Recombinant Human Serum Albumin Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Recombinant Human Serum Albumin Sales Market Share by Application (2018-2023)
Figure 67. Egypt Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Recombinant Human Serum Albumin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Recombinant Human Serum Albumin in 2022
Figure 73. Manufacturing Process Analysis of Recombinant Human Serum Albumin
Figure 74. Industry Chain Structure of Recombinant Human Serum Albumin
Figure 75. Channels of Distribution
Figure 76. Global Recombinant Human Serum Albumin Sales Market Forecast by Region (2024-2029)
Figure 77. Global Recombinant Human Serum Albumin Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Recombinant Human Serum Albumin Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Human Serum Albumin Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Recombinant Human Serum Albumin Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Recombinant Human Serum Albumin Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の組換えヒト血清アルブミン市場予測 2023年-2029年] (コード：LP23DC11411)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の組換えヒト血清アルブミン市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の吸入用組換え新型コロナウイルスワクチン市場予測 2023年-2029年
  • 世界の組換えアルブミン市場2022年：OsrHSA、ScrHSA
  • 世界のアルブミンELISA検査キット市場予測 2023年-2029年
  • 世界の血漿アルブミン市場予測 2023年-2029年
  • 世界の組換えストレプトキナーゼ市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆